Streptomyces griseus - Revision history

Sam Prudence: /* Genomes */

2020-02-20T15:49:43Z

Genomes

← Older revision		Revision as of 15:49, 20 February 2020
Line 19:		Line 19:
	===Links===		===Links===
	===Genomes===		===Genomes===
			Browse the ''S. griseus'' subsp. griseus NBRC 13350 genome and antiSMASH output via the [https://detoxbase.org/projects/Microbiology/ActinoBase/genome/GCF_000010605.1/view ActinoBase MORF Genome Browser].

	===Transcriptomes===		===Transcriptomes===
	===Proteomics===		===Proteomics===

H Otani at 20:56, 4 October 2019

2019-10-04T20:56:26Z

← Older revision		Revision as of 20:56, 4 October 2019
Line 1:		Line 1:
	~~==Organism Page==~~		==''Streptomyces griseus''==

	=== ''Streptomyces griseus'' ===

	===Background===		===Background===

	<em>Streptomyces griseus</em> is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008<sup>1</sup>. <em>S. griseus</em/> is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin.		<em>Streptomyces griseus</em> is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008<sup>1</sup>. <em>S. griseus</em/> is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin.

	~~<sup>1</sup>Ohnishi Y, <em>et al</em>. 2008. Genome Sequence of the Streptomycin-Producing Microorganism <em>Streptomyces griseus</em> IFO 13350. J. Bacteriol. 190: 4050-4060.~~

	===Growth & Maintenance===		===Growth & Maintenance===
Line 22:		Line 18:

	===Links===		===Links===
	=====Genomes=====		===Genomes===
	=====Transcriptomes=====		===Transcriptomes===
	=====Proteomics=====		===Proteomics===
	=====Protocols=====		===Protocols===

	<em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency<sup>2</sup>.		<em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency<sup>2</sup>.

			===Availability===
			===Culture Collections===
			===References===

			<sup>1</sup>Ohnishi Y, <em>et al</em>. 2008. Genome Sequence of the Streptomycin-Producing Microorganism <em>Streptomyces griseus</em> IFO 13350. J. Bacteriol. 190: 4050-4060.

	<sup>2</sup>Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678.		<sup>2</sup>Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678.

	~~====Availability====~~
	~~=====Culture Collections=====~~

H Otani at 04:23, 31 August 2019

2019-08-31T04:23:55Z

← Older revision		Revision as of 04:23, 31 August 2019
Line 5:		Line 5:
	===Background===		===Background===

	<em>Streptomyces griseus</em> is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008. <em>S. griseus</em/> is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin.		<em>Streptomyces griseus</em> is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008<sup>1</sup>. <em>S. griseus</em/> is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin.

			<sup>1</sup>Ohnishi Y, <em>et al</em>. 2008. Genome Sequence of the Streptomycin-Producing Microorganism <em>Streptomyces griseus</em> IFO 13350. J. Bacteriol. 190: 4050-4060.

	===Growth & Maintenance===		===Growth & Maintenance===
Line 25:		Line 27:
	=====Protocols=====		=====Protocols=====

	<em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency.		<em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency<sup>2</sup>.

	Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678.		<sup>2</sup>Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678.

	====Availability====		====Availability====
	=====Culture Collections=====		=====Culture Collections=====

H Otani at 23:29, 30 August 2019

2019-08-30T23:29:07Z

← Older revision		Revision as of 23:29, 30 August 2019
Line 24:		Line 24:
	=====Proteomics=====		=====Proteomics=====
	=====Protocols=====		=====Protocols=====

			<em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency.

			Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678.

	====Availability====		====Availability====
	=====Culture Collections=====		=====Culture Collections=====

H Otani at 21:22, 30 August 2019

2019-08-30T21:22:00Z

← Older revision		Revision as of 21:22, 30 August 2019
Line 4:		Line 4:

	===Background===		===Background===

			<em>Streptomyces griseus</em> is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008. <em>S. griseus</em/> is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin.

	===Growth & Maintenance===		===Growth & Maintenance===

			<em>S. griseus</em> grows well on [[YMPD]] agar and liquid media.

	=====Sporulation=====		=====Sporulation=====

			<em>S. griseus</em> sporulates well on [[YMPD]] agar medium.

	===Strains===		===Strains===
	~~====Superhosts====~~
			<em>Streptomyces griseus</em> IFO 13350

	===Links===		===Links===

CraigAllan: Created page with "==Organism Page== === ''Streptomyces griseus'' === ===Background=== ===Growth & Maintenance=== =====Sporulation===== ===Strains=== ====Superhosts==== ===Links=== =====Ge..."

2019-07-29T10:59:31Z

Created page with "==Organism Page== === ''Streptomyces griseus'' === ===Background=== ===Growth & Maintenance=== =====Sporulation===== ===Strains=== ====Superhosts==== ===Links=== =====Ge..."

New page

==Organism Page==

=== ''Streptomyces griseus'' ===

===Background===

===Growth & Maintenance===
=====Sporulation=====

===Strains===
====Superhosts====

===Links===
=====Genomes=====
=====Transcriptomes=====
=====Proteomics=====
=====Protocols=====

====Availability====
=====Culture Collections=====